Isla Pharmaceuticals Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $563K
Latest Deal Amount
  • Investors
  • 2

Isla Pharmaceuticals General Information

Description

Owner and operator of a biotechnology company intended to develop tropical disease therapies. The company's range of offerings includes the development of treatment of dengue infection and other mosquito-borne illnesses, enabling physicians to treat diseases like malaria easily.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 100 Calle del Muelle, 21007
  • San Juan, PR 00901
  • United States
+1 (510) 000-0000

Isla Pharmaceuticals Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Isla Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 18-Mar-2020 $563K 00.000 00.00 Completed Generating Revenue
2. Early Stage VC (Series B) 00000 00.000 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 30-Apr-2018 $1.12M $1.12M 00.000 Completed Generating Revenue
To view Isla Pharmaceuticals’s complete valuation and funding history, request access »

Isla Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 000,000 00.000000 000.00 000.00 00 00.00 0.000
Series B 00,000 00.000000 00 00 00 00 0.000
Series A 125,000 $0.000100 $9 $9 1x $2.25 13.44%
To view Isla Pharmaceuticals’s complete cap table history, request access »

Isla Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
David Foster Ph.D President & Board Member
To view Isla Pharmaceuticals’s complete executive team members history, request access »

Isla Pharmaceuticals Board Members (4)

Name Representing Role Since
Albert Hansen KESA Partners Board Member 000 0000
David Foster Ph.D Isla Pharmaceuticals President & Board Member 000 0000
Paul MacLeman Self Board Member 000 0000
William Garner MD Self Chairman 000 0000
To view Isla Pharmaceuticals’s complete board members history, request access »

Isla Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EGB Ventures Venture Capital Minority 000 0000 000000 0
KESA Partners Merchant Banking Firm Minority 000 0000 000000 0
To view Isla Pharmaceuticals’s complete investors history, request access »